Your Smile
is Our Goal

Chairman & Managing Director Dr. Peter Mehany ,Global Pharmaceuticals Group & Business Leaders, –CPHI Worldwide Event November 2021


is a group of companies specialized in different type of activities in the pharmaceuticals field including manufacturing, promotion, importation and distribution activities in Egypt. The group is working on an integrated style of business relation with completely independent management to provide the end consumer, the patients, the best quality of products and services. The group activities started in 1997, with Makram Mehany Pharma (MMP), scientific office for sales and marketing, established and grown up to add importation, distribution activities and finally pharmaceuticals production in Egypt. The manufacturing sites are operating with the GMP standards of Pharmaceuticals production.



Integrated business partners


two sales and marketing offices , promoting the products of the 3 plants allover Egypt.

Ramco for Import and Export

is commercial agent representing some APIs producers and finished pharmaceuticals companies in Egypt.

Ramco Pharm

is one of the leading local distribution companies in Egypt, representing several multinational and local pharmaceutical companies.

What Is Group Vision

To share in the creation of a healthy smile on the face of every patient for a life full of happiness and hope

What Is Group Mission

To serve the needs of our customers, doctors, pharmacists and patients by providing them with world-class pharmaceutical products of superior quality at affordable prices for a better and healthier life. To provide employees with work satisfaction and advancement opportunities while ensuring the highest value to all stakeholders including investors, business partners & suppliers.

What are Group Values


Excelling in our products and customer services to exceed their expectations and build long term relationships while keeping focused on business objectives and opportunities for continuous growth.


Doing the right things at all times and in all circumstances, honoring our commitments and being accountable for every action we are involved in.


Building strong borderless teams through focusing on shared goals and removing organizational barriers to create seamless teams smoothly working together towards one vision.


Creating an atmosphere that motivates our employees to be innovative and creative by speaking out freely of their ideas and trying new approaches to foster advancement in skills, technology and processes.


Being determined to achieve our business objectives through flawless implementation of plans and exploring all opportunities for accelerating the business growth.


Pursuing excellence in every detail of business activities will fuel each other towards leadership in the market place. Repeatedly done, excellences then will not be an act, but a habit.


Working with sense of responsibility and contribution to the society and environment defines our existence. It entails making a difference in the quality of lives and environment surrounding us where is being done on both collective as well as individual basis.


is a local investment project established in 1994 dealing with pharmaceutical formulations production in Egypt. In addition to production of GNP products, license agreements were established with multinational pharmaceutical companies, of them, MSD, Sanofi, Novartis, Stada, Elerte, SUN and others. GNP products are covering a wide range of therapeutic areas, with 130 local brands in tablets, capsules, solutions, syrups, ointments, creams, gels, and suppositories.
GNP products are produced with the GMP standards. GNP is awarded ISO 9001 for quality, ISO 14001 for environment and ISO 17025 for quality lab accreditation certificates. GNP was inspected, registered and the products were marketed in Yemen, Sudan, Tanzania, Uganda, Kenya and Eastern Europe (CIS). The company was also inspected and accepted by Romanian Health authorities for European GMP (PIC/s).

"Global Pharmaceutical Industries"

is established, designated for sterile injectable products; in the form of vials and ampoule in solution and lyophilized products.
The products were in the market since November 2011. Also Pfizer, Amoun, SUN, IDI, EVA pharm and others are in contract manufacturing agreements with GPI for production of their injectable products. Around 30 brands are now in the market.
GPI was inspected and approved by Romanian Health Authorities for European GMP (PIC/s), as well as Sudan and Yemen Health Authorities.

"Global Advanced Pharmaceuticals"

is a mega project in Egypt, composed of 6 modules of production for different pharmaceutical forms, Solid Dosage forms, Liquids, Ophthalmic Preparations, Large Volume Intravenous Fluids, Cephalosporin and Oncology products.
The first phase of production, the Solid Dosage forms (Capsules and Tablets) and Blow-Fill-Seal (BFS) line, mainly for ophthalmic preparations, started production in the third quarter 2018.
The capacity of the Solid Dosage form exceeds 100 Million blisters per year. The BFS line is designed for production of multiple and unit-dose forms. Partners are invited to join GAP project in any form of business style.

"Sales & Marketing"

Contact us

  • Human Resources
  • International Markets and Export
  • Business Development
  • Company
  • Pharmacovigilance Department